The possible application of circulating TUG1 as a diagnostic and prognostic biomarker has already been reported in other cancer models.55, 56 To date, UCA1 deregulation in serum exosomes of CRC patients has never been reported; on the contrary, its upregulation was observed in CRC patient plasma.29 This evidence concerns the gene UCA1 and colorectal carcinoma.